Assignee
PAR PHARMACEUTICAL INC
US·41 granted patents·33 pending applications·294 citations·filing 2001–2025
Top patents by PatentIndex Score
74 records- 0198US9375478B1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2015·Granted Jun 28, 2016·24 cites·11 claims
- 0297US10624864B2Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2019·Granted Apr 21, 2020·8 cites·18 claims
- 0397US10010575B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Jul 3, 2018·8 cites·19 claims
- 0497US9981006B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted May 29, 2018·8 cites·19 claims
- 0597US9974827B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted May 22, 2018·8 cites·18 claims
- 0697US9968649B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted May 15, 2018·8 cites·17 claims
- 0797US9962422B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted May 8, 2018·8 cites·17 claims
- 0897US9925233B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Mar 27, 2018·8 cites·24 claims
- 0997US9919026B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Mar 20, 2018·9 cites·14 claims
- 1097US9750785B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Sep 5, 2017·16 cites·11 claims
- 1197US9744239B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2015·Granted Aug 29, 2017·17 cites·19 claims
- 1297US9744209B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Aug 29, 2017·15 cites·13 claims
- 1397US9687526B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2016·Granted Jun 27, 2017·16 cites·20 claims
- 1496US12280024B2Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2023·Granted Apr 22, 2025·1 cites·4 claims
- 1596US11135265B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2019·Granted Oct 5, 2021·4 cites·16 claims
- 1696US9993520B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Jun 12, 2018·6 cites·14 claims
- 1796US9925234B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Mar 27, 2018·6 cites·15 claims
- 1896US9119876B1Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2015·Granted Sep 1, 2015·48 cites·19 claims
- 1995US11207372B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2019·Granted Dec 28, 2021·3 cites·13 claims
- 2095US9937223B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Apr 10, 2018·6 cites·18 claims
- 2194US9295657B1Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2015·Granted Mar 29, 2016·22 cites·21 claims
- 2293US11337938B2Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2020·Granted May 24, 2022·2 cites·18 claims
- 2391US10130592B2Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2015·Granted Nov 20, 2018·10 cites·18 claims
- 2489US2024091176A1Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 2588US11779587B2Vareniciline compound and process of manufacture thereofPAR PHARMACEUTICAL INC·Filed 2022·Granted Oct 10, 2023·1 cites·30 claims
- 2687US11717524B1Varenicline compound and process of manufacture thereofPAR PHARMACEUTICAL INC·Filed 2022·Granted Aug 8, 2023·1 cites·30 claims
- 2785US11602537B2Varenicline compound and process of manufacture thereofPAR PHARMACEUTICAL INC·Filed 2022·Granted Mar 14, 2023·1 cites·11 claims
- 2885US10844435B1Method to treat hypotension using vasopressin in certain genotypesPAR PHARMACEUTICAL INC·Filed 2020·Granted Nov 24, 2020·3 cites·6 claims
- 2984US12440458B2Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2022·Granted Oct 14, 2025·0 cites·20 claims
- 3082US2026041729A1Vasopressin Formulations for Use in Treatment Of HypotensionPAR PHARMACEUTICAL INC·Filed 2024·Application pending·0 cites
- 3182US2026034074A1Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2025·Application pending·0 cites
- 3281US2019201476A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2019·Application pending·0 cites
- 3380US8003353B2Cyanocobalamin low viscosity aqueous formulations for intranasal deliveryPAR PHARMACEUTICAL INC·Filed 2008·Granted Aug 23, 2011·3 cites·6 claims
- 3478US11872234B2Vareniciline compound and process of manufacture thereofPAR PHARMACEUTICAL INC·Filed 2023·Granted Jan 16, 2024·0 cites·30 claims
- 3578US7812120B2Nasal calcitonin formulations containing chlorobutanolPAR PHARMACEUTICAL INC·Filed 2004·Granted Oct 12, 2010·11 cites·19 claims
- 3678US2018333454A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 3778US2018325984A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 3878US2018333453A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 3978US2018325987A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4078US2018325991A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4178US2018325985A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4278US2018325986A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4378US2018325982A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4478US2018325983A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4578US2018325990A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4678US2018325989A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4778US2018325988A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4877US2018133285A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4977US2018153955A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 5076US10920278B1Method to treat hypotension using vasopressin in certain genotypesPAR PHARMACEUTICAL INC·Filed 2020·Granted Feb 16, 2021·1 cites·6 claims
Showing the top 50 of 74 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when PAR PHARMACEUTICAL INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →